… of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign … -
WJ Catalona, AW Partin, KM Slawin, MK Brawer, RC … - The Journal of Urology, 1999 - jurology.com
... Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation
of Prostate Cancer From Benign Prostatic Disease: A Prospective Multicenter ...
DISCRIMINATION OF MEN WITH PROSTATE CANCER FROM THOSE WITH BENIGN DISEASE BY MEASUREMENTS OF HUMAN … -
C BECKER, T PIIRONEN, KIM PETTERSSON, T BJ?RK, KJ … - The Journal of Urology, 2000 - Elsevier
... Discrimination of patients with benign prostate disease from those with prostate
cancer was significantly enhanced using measurements of hK2 in addition to ...
… -matching Algorithm Distinguishes Prostate Cancer from Benign Prostate Hyperplasia and Healthy Men 1 -
BL Adam, Y Qu, JW Davis, MD Ward, MA Clements, LH … - Cancer Research, 2002 - AACR
... Quantitation of serum prostate-specific membrane antigen by a novel protein biochip
immunoassay discriminates benign from malignant prostate disease. ...
… specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate … -
MC Benson, IS Whang, A Pantuck, K Ring, SA Kaplan, … - J Urol, 1992 - ncbi.nlm.nih.gov
... resonance imaging determinations of benign prostatic hypertrophy ... of 61 patients with
prostatic disease clinically confined to the prostate glands (41 ...
Discrimination of Prostate Cancer from Benign Disease by Plasma Measurement of Intact, Free Prostate … -
P Nurmikko, K Pettersson, T Piironen, J Hugosson, … - Clinical Chemistry, 2001 - Am Assoc Clin Chem
... LS Marks, LS Millar, CL Knott, HG Rittenhouse, and SD Mikolajczyk Benign
Prostate-specific Antigen (BPSA) in Serum Is Increased in Benign Prostate Disease ...
… Antigen by a Novel Protein Biochip Immunoassay Discriminates Benign from Malignant Prostate Disease … -
Z Xiao, BL Adam, LH Cazares, MA Clements, JW Davis … - Cancer Research, 2001 - AACR
... Quantitation of Serum Prostate-specific Membrane Antigen by a Novel Protein Biochip
Immunoassay Discriminates Benign from Malignant Prostate Disease 1. ...
… complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate … -
UH Stenman - Cancer Research, 1991 - AACR
... LS Marks, LS Millar, CL Knott, HG Rittenhouse, and SD Mikolajczyk Benign
Prostate-specific Antigen (BPSA) in Serum Is Increased in Benign Prostate Disease ...
Serum Proteomic Patterns for Detection of Prostate Cancer -
EF Petricoin, DK Ornstein, CP Paweletz, A Ardekani … - jnci, 2002 - jnci.oxfordjournals.org
... Quantitation of serum prostate-specific membrane antigen by a novel protein biochip
immunoassay discriminates benign from malignant prostate disease. ...
Etiology and disease process of benign prostatic hyperplasia.
JT Isaacs, DS Coffey - Prostate Suppl, 1989 - ncbi.nlm.nih.gov
Prostate Suppl. 1989;2:33-50. Etiology and disease process of benign prostatic
hyperplasia. Isaacs JT, Coffey DS. Oncology Center ...
[CITATION] … clinical trial evaluation of free PSA in the differentiation of prostate cancer from benign disease
WJ Catalona, AW Partin, KM Slawin, MK Brawer, A … - J Urol, 1997
Source: Google Scholar |